Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 9/2/2025

Management of Normal EKG with Occasional PVCs

  • PVCs are common and increase in frequency with age, with approximately 50% of all people showing PVCs on longer-term monitoring 1
  • Risk factors for PVC-induced cardiomyopathy include high PVC burden (>10-15% of total heartbeats, with highest risk at >20-24%), wider QRS complexes (>160 ms), and short coupling interval (<300 ms) 2
  • Frequent PVCs (usually >15% of total beats) may produce a reversible form of left ventricular (LV) dysfunction, as recommended by the American College of Cardiology 3, 4

Management Algorithm Based on Symptoms and PVC Burden

  • Periodic follow-up with reassessment of ventricular function is warranted if PVCs are frequent enough to potentially cause ventricular dysfunction over time, according to the American College of Cardiology 5
  • First-line treatment for symptomatic patients includes avoidance of aggravating factors such as excessive caffeine, alcohol, or sympathomimetic agents, as recommended by the American College of Cardiology 5
  • Second-line treatment includes beta-blockers (e.g., metoprolol) or non-dihydropyridine calcium channel blockers, which can reduce symptoms but have limited effectiveness in PVC reduction, as stated by the American College of Cardiology 5

Patients with PVC-Induced Cardiomyopathy

  • Pharmacological treatment with beta-blockers or amiodarone is reasonable to reduce arrhythmias and improve LV function, according to the American College of Cardiology 4, 6
  • Catheter ablation is recommended for patients who require arrhythmia suppression for symptoms or declining ventricular function due to frequent PVCs when medications are ineffective, not tolerated, or not preferred, as recommended by the American College of Cardiology 3, 4
  • Ablation success rates of up to 80% have been reported, and LV function normalizes within 6 months in 82% of patients with depressed ventricular function 2, 4

Follow-up Recommendations

  • Monitor PVC burden reduction after initiating therapy, and follow LV function with serial echocardiography to document improvement in patients with PVC-induced cardiomyopathy or high PVC burden, as recommended by the American College of Cardiology 2

Special Considerations

  • PVCs in athletes, especially in the absence of structural heart disease, are generally benign, requiring only limited workup, according to the American College of Cardiology 6
  • In patients with idiopathic VF triggered by PVCs, catheter ablation of the triggering focus has proven highly effective in eliminating the repetitive PVCs, as reported in the European Heart Journal 7, 8

REFERENCES

2

Management of Premature Ventricular Contractions [LINK]

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025